Iain Stuart - 30 Jun 2021 Form 4 Insider Report for VYNE Therapeutics Inc. (VYNE)

Role
Chief Scientific Officer
Signature
/s/ Mutya Harsch, attorney-in-fact for Iain Stuart
Issuer symbol
VYNE
Transactions as of
30 Jun 2021
Net transactions value
-$10,821
Form type
4
Filing time
02 Jul 2021, 16:36:27 UTC
Next filing
03 Sep 2021
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction VYNE Common Stock Tax liability $10,821 -3,083 -3.1% $3.51 95,750 30 Jun 2021 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Represents shares that have been withheld by the Issuer to satisfy tax withholding requirements in connection with the vesting of restricted stock units.